VanEck Biotech ETF BBH
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.35%
- Net assets
- $395.6M
- Holdings
- 25
- 12-month distribution yield
- 0.38%
- Asset class
- Equity
VanEck Biotech ETF (BBH) is an exchange-traded fund listed on the Nasdaq in the United States, issued by VanEck. Its category is Equity · US (equity). Its last price was US$248.78 on 20 Oct 2026. Its expense ratio is 0.35% a year, from its prospectus dated 1 Feb 2026. It reported net assets of US$395.55 million as of 30 Jun 2026. Its latest holdings report lists 25 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$0.96 a unit, a 12-month distribution yield of 0.38%, paid yearly.
Fees
- Total annual operating expenses (gross)
- 0.35%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.35%
- Prospectus date
- 1 Feb 2026
- Filed with the SEC
- 27 Jan 2026
Size and reporting
- Net assets
- $395,554,693
- Total assets
- $395,960,047
- Holdings as of
- 30 Jun 2026
- Report made public
- 26 Aug 2026 (57 days after the month end)
Top holdings
Largest 25 of 25 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | Amgen Inc | US0311621009 | 15.25% | $60.3M | Equity (common) | United States | USD |
| 2 | Gilead Sciences Inc | US3755581036 | 12.79% | $50.6M | Equity (common) | United States | USD |
| 3 | Vertex Pharmaceuticals Inc | US92532F1003 | 9.10% | $36.0M | Equity (common) | United States | USD |
| 4 | Regeneron Pharmaceuticals Inc | US75886F1075 | 6.21% | $24.6M | Equity (common) | United States | USD |
| 5 | Revolution Medicines Inc | US76155X1000 | 5.27% | $20.9M | Equity (common) | United States | USD |
| 6 | Argenx SE | US04016X1019 | 4.97% | $19.7M | Equity (common) | Netherlands | USD |
| 7 | Natera Inc | US6323071042 | 4.92% | $19.5M | Equity (common) | United States | USD |
| 8 | IQVIA Holdings Inc | US46266C1053 | 4.31% | $17.0M | Equity (common) | United States | USD |
| 9 | Alnylam Pharmaceuticals Inc | US02043Q1076 | 3.83% | $15.2M | Equity (common) | United States | USD |
| 10 | Biogen Inc | US09062X1037 | 3.63% | $14.3M | Equity (common) | United States | USD |
| 11 | Moderna Inc | US60770K1079 | 3.36% | $13.3M | Equity (common) | United States | USD |
| 12 | Illumina Inc | US4523271090 | 3.17% | $12.5M | Equity (common) | United States | USD |
| 13 | United Therapeutics Corp | US91307C1027 | 2.83% | $11.2M | Equity (common) | United States | USD |
| 14 | BeOne Medicines Ltd | US07725L1026 | 2.81% | $11.1M | Equity (common) | Switzerland | USD |
| 15 | Insmed Inc | US4576693075 | 2.67% | $10.6M | Equity (common) | United States | USD |
| 16 | Incyte Corp | US45337C1027 | 2.49% | $9.9M | Equity (common) | United States | USD |
| 17 | Neurocrine Biosciences Inc | US64125C1099 | 2.08% | $8.2M | Equity (common) | United States | USD |
| 18 | BioNTech SE | US09075V1026 | 1.94% | $7.7M | Equity (common) | Germany | USD |
| 19 | ICON PLC | IE0005711209 | 1.90% | $7.5M | Equity (common) | Ireland | USD |
| 20 | Bio-Techne Corp | US09073M1045 | 1.54% | $6.1M | Equity (common) | United States | USD |
| 21 | Charles River Laboratories International Inc | US1598641074 | 1.50% | $5.9M | Equity (common) | United States | USD |
| 22 | BioMarin Pharmaceutical Inc | US09061G1013 | 1.34% | $5.3M | Equity (common) | United States | USD |
| 23 | QIAGEN NV | NL0015002SN0 | 1.06% | $4.2M | Equity (common) | Netherlands | USD |
| 24 | Tempus AI Inc | US88023B1035 | 0.98% | $3.9M | Equity (common) | United States | USD |
| 25 | State Street Global Advisors State Street Navigator Securities Lending Government Money Market Portfolio | US8574927062 | 0.06% | $234K | Short-term investment vehicles (cash funds) | United States | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 99.96% | |
| Short-term investment vehicles (cash funds) | 0.06% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 87.33% | |
| Netherlands | 6.04% | |
| Switzerland | 2.81% | |
| Germany | 1.94% | |
| Ireland | 1.90% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 100.02% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 96.01% | |
| Technology | 0.98% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.9570
- 12-month yield
- 0.38%
- Frequency
- Yearly
- Latest ex-date
- 22 Dec 2025
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.9570) ÷ latest price ($248.78) × 100 = 0.38%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (5 payments)
| Ex-date | Amount per unit |
|---|---|
| 22 Dec 2025 | $0.9570 |
| 23 Dec 2024 | $1.2520 |
| 18 Dec 2023 | $0.7130 |
| 19 Dec 2022 | $0.7490 |
| 20 Dec 2021 | $0.3970 |
Filings and sources
- Form N-PORT report for June 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000034406) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- BBH and VTI Vanguard Morningstar Total Stock Market ETF
- BBH and VOO Vanguard S&P 500 ETF
- BBH and IVV iShares Core S&P 500 ETF
- BBH and QQQ Invesco QQQ Trust, Series 1